Hopkins, Benjamin D.
Pauli, Chantal
Du, Xing
Wang, Diana G.
Li, Xiang
Wu, David
Amadiume, Solomon C.
Goncalves, Marcus D.
Hodakoski, Cindy
Lundquist, Mark R.
Bareja, Rohan
Ma, Yan
Harris, Emily M.
Sboner, Andrea
Beltran, Himisha
Rubin, Mark A.
Mukherjee, Siddhartha
Cantley, Lewis C.
Article History
Received: 25 July 2017
Accepted: 26 June 2018
First Online: 4 July 2018
Change Date: 29 August 2018
Change Type: Correction
Change Details: In this Letter, author Xing Du was incorrectly listed as Du Xing; this has been corrected online.
Competing interests
: L.C.C. is a founder and member of the board of directors of Agios Pharmaceuticals and is a founder and receives research support from Petra Pharmaceuticals. S.M. is a founder and on the board of Vor Pharmaceuticals. These companies are developing novel therapies for cancer. All other authors declare no competing interests.